Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Epitope-substituted vaccine for use in improving safety and immunogenicity against dengue viruses

Epitope-substituted vaccine for use in improving safety and immunogenicity against dengue viruses

US Patent 11111276 · Granted Sep 7, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Capture, purification, and release of biological substances using a surface coat2023
Synthetic peptides, pharmaceutical compositions comprising the same, and uses th2022
Peptide-conjugated nanoparticles for targeting, imaging, and treatment of prosta2022
Antibodies, binding fragments, and methods of use2020
Peptides for diagnosis and treatment of cancer2019
Epitope-substituted vaccine for use in improving safety and immunogenicity again2019
Epitope-substituted vaccine for use in improving safety and immunogenicity again2019
Method of treating autoimmune disease by administering antibodies to interleukin2019
Anti-vascular endothelial growth factor receptor 2 (VEGFR2) antibody and methods2019
Compositions and methods for treatment and detection of cancers2018
Compositions and methods relating to universal glycoforms for enhanced antibody 2018
Compositions and methods for treatment and detection of cancers2018